Triple

T5343658
Position Surface form Disambiguated ID Type / Status
Subject World Anti-Doping Code E123999 entity
Predicate linkedDocument P19741 FINISHED
Object International Standard for Therapeutic Use Exemptions E386148 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Standard for Therapeutic Use Exemptions | Statement: [World Anti-Doping Code, linkedDocument, International Standard for Therapeutic Use Exemptions]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: International Standard for Therapeutic Use Exemptions
Context triple: [World Anti-Doping Code, linkedDocument, International Standard for Therapeutic Use Exemptions]
  • A. List of Prohibited Substances and Methods chosen
    The List of Prohibited Substances and Methods is an official international standard that defines which drugs and performance-enhancing techniques are banned in competitive sports.
  • B. World Anti-Doping Code
    The World Anti-Doping Code is the core international document that harmonizes anti-doping policies, rules, and regulations across sports and countries to protect fair play and athlete health.
  • C. ICC Anti-Doping Code
    The ICC Anti-Doping Code is the International Cricket Council’s comprehensive regulatory framework that sets out rules, procedures, and sanctions to prevent and address the use of prohibited performance-enhancing substances in international cricket.
  • D. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • E. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd464be27081908807b40b75c1bbae completed March 20, 2026, 1:06 p.m.
NER Named-entity recognition batch_69bd85e86edc81908d87933db6489f91 completed March 20, 2026, 5:37 p.m.
NED1 Entity disambiguation (via context triple) batch_69bf18ce6aac819093b36992303c5b1c completed March 21, 2026, 10:16 p.m.
Created at: March 20, 2026, 2:01 p.m.